surmount-1 tirzepatide non-diabetic obesity weight loss after intensive lifestyle intervention in adults with overweight or obesity: the SURMOUNT-3 phase 3 trial For the first time, tirzepatide
Description
The available doses are 2.5 mg, 5 mg, 7.5 mg, 10 mg, 12.5 mg, and 15 mg
For very small volumes (under 10 units), it can represent a meaningful percentage of your dose
What syringe should I use for tirzepatide
A 0.3 mL syringe with 0.5-unit graduations gives you the precision needed for small volumes
For 60 units, the math looks like this: Step 1: Divide 60 units by 100 to get the volume in mL
Tirzepatide is given by injection into under the skin in the thigh, abdomen, or upper arm as directed by your doctor, usually once every 7 days for 4 weeks
